HomeKYMR • NASDAQ
add
Kymera Therapeutics Inc
Previous close
$90.10
Day range
$86.11 - $89.20
Year range
$19.45 - $103.00
Market cap
7.18B USD
Avg Volume
822.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.87M | -61.18% |
Operating expense | 16.94M | 3.69% |
Net income | -86.98M | -22.94% |
Net profit margin | -3.03K | -216.73% |
Earnings per share | -0.98 | -10.11% |
EBITDA | -97.46M | -21.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 848.28M | 73.56% |
Total assets | 1.74B | 78.20% |
Total liabilities | 163.15M | 14.56% |
Total equity | 1.58B | — |
Shares outstanding | 81.64M | — |
Price to book | 4.64 | — |
Return on assets | -17.21% | — |
Return on capital | -18.18% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -86.98M | -22.94% |
Cash from operations | -66.75M | -8.03% |
Cash from investing | -394.40M | -675.19% |
Cash from financing | 705.22M | 25,405.21% |
Net change in cash | 244.07M | 2,456.02% |
Free cash flow | -33.56M | 10.42% |
About
Founded
2015
Headquarters
Website
Employees
238
